APA

Cheng Y., Li S., Wang M., Cheng C. & Liu R. (20190213). Peroxisome Proliferator Activated Receptor gamma (PPARγ) Agonist Rosiglitazone Ameliorate Airway Inflammation by Inhibiting Toll-Like Receptor 2 (TLR2)/Nod-Like Receptor with Pyrin Domain Containing 3 (NLRP3) Inflammatory Corpuscle Activation in Asthmatic Mice. : Medical science monitor : international medical journal of experimental and clinical research.

Chicago

Cheng Yinzhi, Li Shuai, Wang Muzi, Cheng Cheng and Liu Rongyu. 20190213. Peroxisome Proliferator Activated Receptor gamma (PPARγ) Agonist Rosiglitazone Ameliorate Airway Inflammation by Inhibiting Toll-Like Receptor 2 (TLR2)/Nod-Like Receptor with Pyrin Domain Containing 3 (NLRP3) Inflammatory Corpuscle Activation in Asthmatic Mice. : Medical science monitor : international medical journal of experimental and clinical research.

Harvard

Cheng Y., Li S., Wang M., Cheng C. and Liu R. (20190213). Peroxisome Proliferator Activated Receptor gamma (PPARγ) Agonist Rosiglitazone Ameliorate Airway Inflammation by Inhibiting Toll-Like Receptor 2 (TLR2)/Nod-Like Receptor with Pyrin Domain Containing 3 (NLRP3) Inflammatory Corpuscle Activation in Asthmatic Mice. : Medical science monitor : international medical journal of experimental and clinical research.

MLA

Cheng Yinzhi, Li Shuai, Wang Muzi, Cheng Cheng and Liu Rongyu. Peroxisome Proliferator Activated Receptor gamma (PPARγ) Agonist Rosiglitazone Ameliorate Airway Inflammation by Inhibiting Toll-Like Receptor 2 (TLR2)/Nod-Like Receptor with Pyrin Domain Containing 3 (NLRP3) Inflammatory Corpuscle Activation in Asthmatic Mice. : Medical science monitor : international medical journal of experimental and clinical research. 20190213.